← All posts

The Price Tag Question: What Happens When Patients Become Shoppers

This isn’t a story about healthcare fraud. It’s a story about what happens when consumers can finally see the price tags, and the stories they tell themselves about what those numbers mean.

The Moment Everything Changed

In January 2021, every hospital in America was required to do something it had never done before: publish its prices online. Not vague estimates. Not “call for a quote.” Actual numbers for 300 common procedures.

Policymakers had a simple theory: give people prices, and they’ll shop around; competition drives costs down. The kind of logic that works beautifully for buying cars.

Except healthcare isn’t cars. And patients aren’t shoppers.

The Stories We Tell About Money and Mortality

Here’s what nobody predicted: when consumers finally get price information, they don’t just calculate. They narrate.

A woman sees two hospitals offering hip replacements. Hospital A: $15,000. Hospital B: $12,000. But she doesn’t see numbers. She sees “the place where my friend had complications” versus “the hospital that saved my mother.” She sees “too cheap to be good” versus “they must be desperate for patients.”

She builds an entire story around those prices: about fairness, about what she deserves, about what high prices must mean about quality.

And that story often matters more than the numbers.

The Mental Accounting Problem

Consider what happened with pre-payment plans for healthcare.

Some hospitals now let you lock in prices. Pay $25,000 upfront for your surgery, no surprises later. Peace of mind, right?

Except something unexpected happened. Patients who prepaid started skipping follow-up appointments. Not consciously. Not deliberately. But psychologically, they had already “dealt with” their health issue. The payment closed the mental account. The narrative was complete.

The dollars went out, the procedure got done, the story ended.

Never mind that the follow-ups were medically critical. The financial story felt finished.

The Illusion of Shopping

Or take Sarah, a patient from my research who lives in Colorado and has good insurance. Her colonoscopy costs $2,200 at the local hospital. An hour away, it’s $545. Four times cheaper.

Does she drive the hour? No.

Why would she? Her co-pay is the same either way. The insurance company pays the difference. The system has trained her not to care about the actual price.

The legislation assumes she’ll shop. But the real price she pays, the only price in her story, is $50. That number doesn’t change based on which hospital she picks.

So she doesn’t pick. She goes to the one her doctor recommends. Or the closest one. Or the one where her sister had good care.

Price transparency gave her information she cannot use to change the story that actually matters to her.

The Numbers Behind the Narrative

Between 2015 and 2019, Americans’ healthcare spending jumped 22%. That’s an extra $1,074 per person. But here’s the twist: people used less healthcare in 2019 than in 2015.

More money. Less care. Pure price inflation.

And now, with transparency, hospitals are publishing those inflated prices. A colonoscopy with a list price of $3,621 and a cash price of $2,249. The same procedure. The same ten minutes. Two wildly different stories about what it’s worth.

What Nobody Expected

First: price transparency created an entirely new market. But it wasn’t patients shopping. It was tech companies building apps to help people navigate the chaos. Information brokers now sit between patients and hospitals, making money from healthcare data. So far, they are the real winners.

Second: the people most likely to shop aren’t the uninsured poor, who have no choice, or the well-insured rich, who don’t care. It’s the squeezed middle: people with high-deductible plans who feel every dollar but still have the resources to research alternatives.

They’re the only ones whose story includes both caring about price and having the ability to act on it.

Third: hospitals with higher quality ratings charge more. That sounds obvious. Except the link is weak. A five-star hospital might charge $1,827 while a one-star hospital charges $1,387. Barely 30% more for dramatically different outcomes.

The price signals are noisy. Consumers shopping on price alone might be making terrible decisions. But they don’t know that. Their story says, “I found a good deal.”

The Psychological Trap

Here’s the deeper problem: healthcare decisions aren’t shopping decisions. They’re existential calculations.

When you’re comparing prices, you’re not thinking about your wallet. You’re thinking about your mortality. You’re weighing the cost of peace of mind. You’re asking impossible questions:

“What’s my knee worth?”

“How much should I pay to reduce my child’s cancer risk from 5% to 4%?”

“Am I putting my family at risk if I choose the cheaper hospital?”

No one makes those decisions with a calculator, even with perfect information.

So they narrate. They tell themselves stories:

  • “I pre-paid, so I’m done worrying.”
  • “The expensive hospital must be better.”
  • “I trust my doctor more than some website.”
  • “If I shop around, am I gambling with my life?”

These narratives aren’t irrational. They’re coping mechanisms for impossible choices.

What This Means for Healthcare Investors

If you invest in healthcare, whether hospitals, insurance, or health tech, understand this: price transparency alone won’t make healthcare work like a normal market.

The opportunity isn’t in lower prices. It’s in better stories.

The companies that win will help patients make sense of healthcare prices, not just see them:

  • Decision tools that account for quality, outcomes, and distance, not just cost
  • Interfaces that reduce the psychological burden of impossible choices
  • Systems that align what patients pay with what they actually value

The losers? Hospitals that assumed transparency wouldn’t matter because patients don’t really shop. (They do, just not the way economists predicted.) And health tech companies that build price comparison tools treating colonoscopies like airline tickets.

The Question That Really Matters

The real question isn’t “Will price transparency lower healthcare costs?”

It’s this: How will consumers narrate and justify their healthcare expenses when they can finally see what they’re paying?

The answer will determine where billions of dollars flow over the next decade.

The woman choosing between hospitals will tell herself a story. The man prepaying for surgery will tell himself a story. The mother comparing pediatricians will tell herself a story.

Those stories will reshape American healthcare. Not the spreadsheets. Not the algorithms. Not the legislation.

Want to understand how these consumer narratives affect your market or portfolio? I work with healthcare investors and executives to decode how transparency legislation is reshaping patient behavior, and where the real opportunities are. Let’s talk.

This post draws on research I published with Deidre Popovich in the Journal of Consumer Affairs: Examining Legislation and Trends in Healthcare Pricing (2023).

Kelli

Kelli Frias is a Provost Associate Professor of Marketing at American University’s Kogod School of Business and Principal Investigator of the HealthCARE Lab. She studies how people make decisions in markets that were never designed for them.

The newsletter · Monthly

Invisible Decisions

One decision, explained. A monthly note on how people really decide in healthcare and markets, and what organizations should do about it.